CVFG LLC’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.09M Sell
67,450
-1,050
-2% -$16.8K 0.12% 140
2026
Q2
$1.16M Buy
68,500
+1,050
+2% +$16.8K 0.12% 137
2026
Q1
$1000K Buy
+67,450
New +$986K 0.12% 137

Other funds holding AUPH

CVFG LLC's AUPH Position: Q3 2026 in Review

CVFG LLC reduced its Aurinia Pharmaceuticals (AUPH) stake by 1.5% in Q3 2026, selling an estimated $16.8K and leaving 67,450 shares worth $1.09M. The position accounts for 0.12% of the portfolio, ranked #140.

CVFG LLC first reported a position in AUPH in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.16M in Q2 2026. 277 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • CVFG LLC held 67,450 shares of Aurinia Pharmaceuticals worth $1.09M as of Q3 2026.
  • CVFG LLC sold 1,050 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $16.8K.
  • Aurinia Pharmaceuticals made up 0.12% of CVFG LLC's portfolio in Q3 2026, its #140 holding.
  • CVFG LLC first reported a position in Aurinia Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • CVFG LLC's Aurinia Pharmaceuticals position peaked at $1.16M in Q2 2026.
  • 277 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on CVFG LLC's 13F filing for Q3 2026, filed 12 Nov 2026.